CHARACTERISTICS AND MECHANISM OF NEURO‐MUSCULAR BLOCK IN MYASTHENIA GRAVIS
1976; Wiley; Volume: 274; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1976.tb47683.x
ISSN1749-6632
Autores Tópico(s)Plant and Biological Electrophysiology Studies
ResumoAnnals of the New York Academy of SciencesVolume 274, Issue 1 p. 143-173 CHARACTERISTICS AND MECHANISM OF NEURO-MUSCULAR BLOCK IN MYASTHENIA GRAVIS David Grob, David Grob Department of Medicine, Maimonides Medical Center, Brooklyn, New York 11219. State University of New York, College of Medicine Downstate Medical Center, Brooklyn, New York 11203Search for more papers by this authorTatsuji Namba, Tatsuji Namba Department of Medicine, Maimonides Medical Center, Brooklyn, New York 11219. State University of New York, College of Medicine Downstate Medical Center, Brooklyn, New York 11203Search for more papers by this author David Grob, David Grob Department of Medicine, Maimonides Medical Center, Brooklyn, New York 11219. State University of New York, College of Medicine Downstate Medical Center, Brooklyn, New York 11203Search for more papers by this authorTatsuji Namba, Tatsuji Namba Department of Medicine, Maimonides Medical Center, Brooklyn, New York 11219. State University of New York, College of Medicine Downstate Medical Center, Brooklyn, New York 11203Search for more papers by this author First published: May 1976 https://doi.org/10.1111/j.1749-6632.1976.tb47683.xCitations: 33AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Brown, G. L. & A. M. Harvey. 1940. The effects of changes in dietary calcium on neuromuscular transmission. J. Physiol. 97: 330–340. 2 Brooks, V. B. 1956. Effect of botulinus toxin on neuromuscular transmission. J. Physiol. 134: 264–270. 3 Schueler, F. W. 1955. A new group of respiratory paralyzants. I. The “hemicholiniuins. J. Pharmacol. Exp. Therap. 115: 127–140. 4 Grob, D. 1967. Neuromuscular blocking drugs. Physiol. Pharmacol. 3: 389–460. 5 Hubbard, J. I. & D. F. Wilson. 1970. Neuromuscular transmission in a mammalian preparation in the absence of blocking drugs and the effect of d-tubocurarine. J. Physiol. 228: 307–318. 6 Castillo, J. del & B. Katz. 1957. Interaction at end-plate receptors between different choline derivatives. Proc. R. Soc. B 146: 369–381. 7 Zaimis, E. J. 1953. Motor end-plate differences as a determining factor in the mode of action of neuromuscular blocking substances. J. Physiol. 122: 238–251. 8 Jewell, P. A. & E. J. Zaimis. 1954. A differentiation between red and white muscle in the cat based on responses to neuromuscular blocking agents. J. Physiol. 124: 417–428. 9 Grob, D., R. J. Johns & A. M. Harvey. 1956. Studies in neuromuscular function. III. Stimulating and depressant effects of acetylcholine and choline in normal subjects. Bull. Johns Hopkins Hosp. 99: 136–152. 10 Grob, D., R. J. Johns & A. M. Harvey. 1956. Studies in neuromuscular function. V. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in normal subjects. Bull. Johns Hopkins Hosp. 99: 195–218. 11 Johns, R. J., D. Grob & A. M. Harvey. 1956. Studies in neuromuscular function II. Effects of nerve stimulation in normal subjects and in patients with myasthenia gravis. Bull. Johns Hopkins Hosp. 99: 125–135. 12 Walker, M. B. 1934. Treatment of myasthenia gravis with physostigmine. Lancet i: 1200–1201. 13 Harvey, A. M. & R. L. Masland. 1941. Actions of curarizing preparations in the human. J. Pharmacol. Exp. Therap. 73: 304–311. 14 Desmedt, J. E. 1958. Myasthenia-like features of neuromuscular transmission after administration of an inhibitor of acetylcholine synthesis. Nature 182: 1973–1974. 15 Desmedt, J. E. 1966. Presynaptic mechanisms in myasthenia gravis. Ann. N.Y. Acad. Sci. 135: 209–246. 16 Elmqvist, D., W. W. Hofmann, J. Kugelberg & D. M. J. Quastel. 1964. An electrophysiological investigation of neuromuscular transmission in myasthenia gravis. J. Physiol. 174: 417–434. 17 Dahlback, O., D. Elmqvist, T. R. Johns, S. Radner & S. Thesleff. 1961. An electrophysiologic study of the neuromuscular junction in myasthenia gravis. J. Physiol. 156: 336–343. 18 Buchthal, F. & L. Engbaek. 1948. On the neuromuscular transmission in normal and myasthenic subjects. Acta Psych. Neurol. 23: 3–11. 19 Grob, D. 1971. Spontaneous end-plate activity in normal subjects and in patients with myasthenia gravis. Ann. N.Y. Acad. Sci. 183: 248–269. 20 Grob, D., R. J. Johns & A. M. Harvey. 1956. Studies in neuromuscular function. IV. Stimulating and depressant effects of acetylcholine and choline in patients with myasthenia gravis, and their relationship to the defect in neuro-muscular transmission. Bull. Johns Hopkins Hosp. 99: 153–181. 21 Grob, D., T. Namba & D. S. Feldman. 1966. Alterations in reactivity to acetylcholine in myasthenia gravis and carcinomatous myopathy. Ann. N.Y. Acad. Sci. 135: 247–275. 22 Grob, D. 1956. Studies in neuromuscular function. I. Introduction and methods. Bull. Johns Hopkins Hosp. 99: 115–124. 23 Grob, D., R. J. Johns & A. M. Harvey. 1956. Studies in neuromuscular function. VI. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in patients with myasthenia gravis. Bull. Johns Hopkins Hosp. 99: 219–238. 24 Grob, D. 1961. Further studies on the mechanism of the defect in neuromuscular transmission in myasthenia gravis, with particular reference to the acetyl-choline-insensitive block. In Myasthenia H. R. Viets Gravis, Ed.: 127–149. Charles C Thomas, Publisher. Springfield , Ill . 25 Liley, A. W. & K. A. K. North. 1953. An electrical investigation of effects of repetitive stimulation on mammalian neuromuscular junction. J. Neurophysiol. 16: 509–527. 26 Dahlback, O., D. Elmqvist, T. R. Johns, S. Radner & S. Thesleff. 1961. An electrophysiologic study of the neuromuscular junction in myasthenia gravis. J. Physiol. 156: 336–343. 27 Katz, D. & S. Thesleff. 1957. In study of the “desensitization” produced by acetylcholine at the motor end-plate. J. Physiol. 138: 63–80. 28 Elmqvist, D. 1965. Neuromuscular transmission with special reference to myasthenia gravis. Acta Physiol. Scand. 64 (Suppl. 249): 1–34. 29 Fambrough, D., D. B. Drachman & S. Satyamurti. 1973. Neuromuscular junctions in myasthenia gravis: decreased acetylcholine receptors. Science 182: 293–295. 30 Gage, P. W. 1976. Generation of end-plate potentials. Physiol. Rev. 56: 177–247. 31 Fatt, P. & B. Katz. 1951. An analysis of the end-plate potential recorded with an intracellular electrode. J. Physiol. 115: 320–370. 32 Hubbard, J. I., R. F. Schmidt & T. Yokota. 1965. The effect of acetylcholine upon mammalian motor nerve terminals. J. Physiol. 181: 810–829. 33 Armett, C. J. & J. M. Ritchie. 1960. The action of acetylcholine on conduction in mammalian non-myelinated fibers and its prevention by an anticholinesterase. J. Physiol. 152: 141–158. Citing Literature Volume274, Issue1Myasthenia GravisMay 1976Pages 143-173 ReferencesRelatedInformation
Referência(s)